Get started today

Case Study: Diabetes

Presented by Dr Philip Blair, MD

About this module:

Diabetes is an inflammatory condition and the pathophysiological pathways involved are complex. The endocannabinoid system is involved in diabetes pathogenesis and there is a growing evidence body that cannabidiol (CBD) may be able to address the underlying pathology as well as treat several of the complications of diabetes. This presentation explores the role of the endocannabinoid system in diabetes type 2 pathophysiology, and the mechanisms of action of CBD relevant to its treatment. It will conclude with dosing guidelines and a case study.

This presentation is pitched at healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics. 

Learning Outcomes

At the end of this module, learners will be able to:

  • Explain key pathways involved in diabetes including the role of the glycocalyx.
  • Argue the evidence for involvement of the endocannabinoid system in diabetes pathophysiology.
  • Debate the mechanisms of action of CBD in addressing diabetes.
  • Describe some of the complications of diabetes that CBD may be able to address.
  • Formulate a treatment strategy for diabetes type 2 using medicinal cannabis.

Dr Philip Blair, MD

Dr. Philip Blair, MD, (Colonel, US Army, retired) is a Family Physician and consultant in disease management in the Northwest USA. He graduated from West Point in 1972, attended the University of Miami School of Medicine, training as an Army Family Physician and serving as a combat physician in the first Gulf War. After medical assignments in three continents and 29 years in uniform, he retired from the Army and has been consulting on complex disease management since 2000.

Dr. Blair has been studying, treating, and lecturing about the human body’s natural endocannabinoid system (ECS) since 2014. His goal is to restore health and performance by enhancing the ECS using diet, exercise, appropriate medications and non-psychoactive therapies.
Created with